PolyPeptide Group AG (XSWX:PPGN) Change In Receivables : CHF-28.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Change In Receivables?

PolyPeptide Group AG's change in receivables for the quarter that ended in Dec. 2023 was CHF-2.3 Mil. It means PolyPeptide Group AG's Accounts Receivable increased by CHF2.3 Mil from Jun. 2023 to Dec. 2023 .

PolyPeptide Group AG's change in receivables for the fiscal year that ended in Dec. 2023 was CHF-27.7 Mil. It means PolyPeptide Group AG's Accounts Receivable increased by CHF27.7 Mil from Dec. 2022 to Dec. 2023 .

PolyPeptide Group AG's Accounts Receivable for the quarter that ended in Dec. 2023 was CHF72.3 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PolyPeptide Group AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 74.22.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PolyPeptide Group AG's liquidation value for the six months ended in Dec. 2023 was CHF-85.3 Mil.

PolyPeptide Group AG Change In Receivables Historical Data

The historical data trend for PolyPeptide Group AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Change In Receivables Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

8.91

-23.17

-12.74

18.54

-27.68

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial					-22.39	15.17	3.94	-26.25	-2.30

PolyPeptide Group AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-28.5 Mil.

PolyPeptide Group AG (XSWX:PPGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PolyPeptide Group AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	72.309	/	177.806	*	91
=	74.22

2. In Ben Graham's calculation of liquidation value, PolyPeptide Group AG's accounts receivable are only considered to be worth 75% of book value:

PolyPeptide Group AG's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	90.258	-	290.338	+	0.75 * 72.309	+	0.5 * 121.192
=	-85.3

PolyPeptide Group AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines